NygaardIBarberMDBurgioKL. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–1316.
2.
HeitMRosenquistCCulliganPGrahamCMurphyMShottS. Predicting treatment choice for patients with pelvic organ prolapse. Obstet Gynecol. 2003;101(6):1279–1284.
3.
BarberMDViscoAGWymanJFFantlJABumpRC. Sexual function in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol. 2002;99(2):281–289.
4.
MoalliPAJonesISMeynLAZyczynskiHM. Risk factors associated with pelvic floor disorders in women undergoing surgical repair. Obstet Gynecol. 2003;101(5 Pt 1):869–874.
5.
AlarabMKufaishiHLyeSDrutzHShynlovaO. Expression of extracellular matrix-remodeling proteins is altered in vaginal tissue of premenopausal women with severe pelvic organ prolapse. Reprod Sci. 2014;21(6):704–715.
6.
KufaishiHAlarabMDrutzHLyeSShynlovaO. Static mechanical loading influences the expression of extracellular matrix and cell adhesion proteins in vaginal cells derived from premenopausal women with severe pelvic organ prolapse [published online ahead of print January 27, 2016]. Reprod Sci. doi:10.1177/1933719115625844.
7.
KufaishiHAlarabMDrutzHLyeSShynlovaO. Comparative characterization of vaginal cells derived from premenopausal women with and without severe pelvic organ prolapse. Reprod Sci. 2016;23(7):931–943.
